Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Longeveron Announces Phase 1 Safety, Efficacy Results for Allogeneic Stem Cell Treatment

americanpharmaceuticalreviewMay 17, 2017

Tag: safety , Stem Cell

PharmaSources Customer Service